VERSATOPE THERAPEUTICS INC
LOWELL, MASSACHUSETTS 018524574
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $9.46M | 19 |
Contract Awards
11 awards found
DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIOTHREAT AGENTS, ANTIMICROBIAL-RESISTANT INFECTIONS AND EMERGING INFECTIOUS DISEASES.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
Business Details
- UEI
- VSMPM3EGYYA6
- CAGE Code
- 7TEE7
- Address
- 110 CANAL ST FL 4
LOWELL, MA 018524574 - Congressional District
- MA-03
- Phone
- 8575266657
Parent Company
VERSATOPE THERAPEUTICS INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov